Browsing Tag
metastatic prostate cancer
3 posts
ATNM-400 from Actinium Pharmaceuticals (ATNM) shows breakthrough promise in resistant breast cancer
Actinium’s ATNM-400 shows potent activity in resistant breast cancer and TNBC. Find out what the new SABCS 2025 data reveal about this radiopharma candidate.
Janux Therapeutics advances prostate cancer treatment as stock soars
Janux Therapeutics made headlines with an extraordinary 54% surge in after-hours trading on Monday, bringing its stock price…
Game-changer for prostate cancer: Veracyte’s test predicts who will benefit from chemo
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, has announced compelling new data from the phase 3…